Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 18 studies | 39% ± 13% | |
brain | 18 studies | 35% ± 18% | |
peripheral blood | 17 studies | 35% ± 11% | |
intestine | 11 studies | 30% ± 13% | |
eye | 11 studies | 42% ± 15% | |
kidney | 8 studies | 32% ± 9% | |
liver | 6 studies | 38% ± 18% | |
lymph node | 5 studies | 39% ± 9% | |
pancreas | 4 studies | 60% ± 25% | |
bone marrow | 4 studies | 30% ± 9% | |
heart | 4 studies | 23% ± 5% | |
uterus | 4 studies | 47% ± 17% | |
breast | 4 studies | 36% ± 5% | |
prostate | 4 studies | 30% ± 12% | |
adipose | 4 studies | 31% ± 7% | |
placenta | 3 studies | 50% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6384.32 | 1445 / 1445 | 100% | 136.13 | 183 / 183 |
ovary | 100% | 8389.56 | 180 / 180 | 100% | 88.43 | 430 / 430 |
lung | 100% | 8405.30 | 577 / 578 | 100% | 116.03 | 1155 / 1155 |
breast | 100% | 8655.62 | 459 / 459 | 100% | 133.50 | 1116 / 1118 |
brain | 100% | 5305.89 | 2636 / 2642 | 100% | 91.07 | 704 / 705 |
bladder | 100% | 7163.52 | 21 / 21 | 100% | 93.98 | 502 / 504 |
prostate | 100% | 8031.67 | 245 / 245 | 100% | 120.07 | 500 / 502 |
intestine | 100% | 7652.66 | 966 / 966 | 99% | 102.48 | 523 / 527 |
thymus | 100% | 10159.40 | 653 / 653 | 99% | 111.42 | 600 / 605 |
uterus | 100% | 7816.97 | 170 / 170 | 99% | 96.07 | 455 / 459 |
pancreas | 100% | 7155.93 | 328 / 328 | 99% | 89.71 | 176 / 178 |
stomach | 100% | 6572.04 | 359 / 359 | 99% | 107.93 | 282 / 286 |
kidney | 100% | 6363.40 | 89 / 89 | 98% | 90.86 | 884 / 901 |
adrenal gland | 100% | 9511.94 | 258 / 258 | 97% | 69.58 | 224 / 230 |
liver | 100% | 6852.34 | 226 / 226 | 96% | 67.71 | 390 / 406 |
skin | 100% | 8778.71 | 1809 / 1809 | 92% | 69.72 | 432 / 472 |
adipose | 100% | 8380.43 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6784.09 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 64.58 | 29 / 29 |
muscle | 100% | 7158.86 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 7732.64 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 89.07 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 34.28 | 1 / 1 |
heart | 98% | 4349.05 | 840 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 88% | 4833.77 | 819 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 60% | 28.23 | 48 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006986 | Biological process | response to unfolded protein |
GO_0036503 | Biological process | ERAD pathway |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005635 | Cellular component | nuclear envelope |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | UBXN4 |
Protein name | UBX domain protein 4 UBX domain-containing protein 4 (Erasin) (UBX domain-containing protein 2) UBX domain protein 4 (UBXN4 protein) |
Synonyms | UBXD2 KIAA0242 UBXDC1 |
Description | FUNCTION: Involved in endoplasmic reticulum-associated protein degradation (ERAD). Acts as a platform to recruit both UBQLN1 and VCP to the ER during ERAD . . |
Accessions | Q92575 ENST00000426921.5 Q6PJ80 F8WB86 ENST00000272638.14 C9JLR4 ENST00000415164.5 ENST00000416538.5 |